Metastasis is the MC malignancy of bone.
Breast cancer is the MC primary site.
Others include:
Prostate ,Lung ,Kidney and thyroid
Nature of metastasis
Osteolytic:
Destructive
Most mets (breast**, lung, kidney etc)
Osteoblastic:
Reactive new bone formation
Carcinoma prostate**, breast Ca.
3. 3
• Metastasis is the MC malignancy of bone.
– Breast cancer is the MC primary site.
– Others include:
• Prostate ,Lung ,Kidney and thyroid
• Nature of metastasis
– Osteolytic:
• Destructive
• Most mets (breast**, lung, kidney etc)
– Osteoblastic:
• Reactive new bone formation
• Carcinoma prostate**, breast Ca.
8. 8
Primary Bone tumors: Clinical presentation
• Benign tumors:
– Usually asymptomatic
– Present as painless mass
• *Osteoid osteomas are painful,
• *Enchondromas may cause a stress #.
– Usually detected incidentally.
• Malignant tumors:
– Present with :
• Pain
• Swelling or a
• Pathological fracture
9. 9
Important parameters for diagnosis of
bone tumors
1. Age of patient
2. Bone involved
3. Specific area within the bone (epiphysis,
metaphysis, diaphysis)
4. Radiographic appearance
5. Gross and microscopic features
10. 10
Age and bone tumors
• Remember these general age ranges:
– Metastatic neuroblastoma*: infants &
toddlers
– Ewing's sarcoma: older children &
adolescents (5-20)
– Osteosarcoma: adolescents and young
adults(10—20).
– Giant cell tumors: young adults & middle age
(20-40)
– Chondrosarcoma: middle age (40-60)
– Multiple myeloma : middle to old age (>40)
– Metastatic cancer: middle and old age
13. 13
Risk factors for bone sarcoma
• Include
– some familial syndromes (e.g Li Fraumeni)
– radiation therapy.
• However, most cases are unrelated to any of
these.
• In the previously irradiated patient, the
commonest primary bone cancer:
– osteosarcoma **
14. 14
Treatment
• Benign tumors may be treated by
– curettage and
– packing with bone chips from elsewhere.
• Malignant tumors require
– resection,
– radiation, and/or chemotherapy.
• Osteosarcoma and Ewing's sarcoma often
respond well to chemotherapy.
15. 15
Classification of primary bone tumors
• Primary BT classified in to ten groups
1. Osteogenic (bone forming)
– Benign: osteoma, osteoid osteoma* and
osteoblastoma
– malignant: Osteosarcoma (osteogenic
sarcoma)*
2. Chondrogenic (cartilage forming)
– Benign: osteochondroma*, chondroma*,
chondroblastoma
– malignant: chondrosarcoma*
3. Unknown origin:
– Giant cell tumor* (benign / malignant)
– Ewing’s sarcoma* (malignant)
18. 18
Osteoma
• A benign bone forming tumor.
• Occurs in middle aged adults (40-50yrs)
• Sites:
– usually occurs in the skull (sinuses – most
common) ,facial bones and jaw.
• Usually harmless, they may impinge on the
brain, obstruct sinus drainage, or look ugly.
• Histologically resemble normal bone
• If multiple, suspect Gardener's syndrome
20. 20
• A benign painful* tumor of osteoblasts.
• Occurs in individuals 5-25 yrs old.
• Sites:
– Metaphysis/diaphysis of femur and tibia
– cortex of bone (size: <2cm*)
• Clinical:
– well-localized pain (Nocturnal).
– pain is relieved by aspirin
• Micro:
– Central nidus of osteoid surronded by dense sclerotic
rim of bone
• X ray reveals:
– a small radiolucent focus (nidus) surrounded by densely
sclerotic bone.
Osteoid osteoma***
23. 23
• *Osteoblastoma ("giant
osteoid osteoma"):
– Similar to osteoid
osteoma
– But is larger (>2cm)
and
– Arises in the
vertebral bodies
– Pain not worse at
night and not relived
by aspirin.
26. 26
Osteosarcoma (= osteogenic sarcoma)
• Cancer of the osteoblasts
• The malignant tumor cells make osteoid.
• The 2nd MC primary malignant tumor of bone
(1st is multiple myeloma).
• Age: (bimodal)
– 10-20 years old
• Arises de novo.
– >40 years old
• Usually secondary to risk factors (Paget’s
disease of bone etc.)
27. 27
• Location:
– Most in the
metaphyseal region
of long bones.
• Lower end of
femur (most
common)
• Upper end of tibia
• Upper end of
humerus
– Less commonly in flat
bones jaw.
29. 29
• Osteosarcoma: TYPES:
– Primary Osteosarcoma
• Arise in absence of associated bone
disease.
• In patients < 20 years
• From metaphyseal region of long bones.
• Genetic association:
– 2/3rd show inactivation of Rb gene**
– Common in Li-Fraumeni syndrome** (p53
gene inactivation)
– Secondary Osteosarcoma
• Occurs in older people
• Both in flat and long bones
• In a background of preexisting bone
disease
30. 30
Risk factors for osteosarcoma
• Paget’s disease of bone
– Osteosarcoma of the pelvic bones
• Irradiation (radium watch dial workers)
• Bone infarct
• Osteomyelitis
• Clinical features:
– Local pain, tenderness , swelling and
pathological fracture
35. 35
• Gross:
– Gray white mass with areas of
hemorrhage and necrosis
– Destroys cortex and invades adjacent
soft tissue
• Elevates the Periosteum , producing
Codman’s triangle on X ray.
• Sunburst appearance : due to
calcified osteoid extending into the
adjacent soft tissue.
38. 38
• Microscopy:
– Tumor cells produce osteoid.
– Tumor cells may be spindle, oval or round.
• Spread:
– Metastasize through blood stream lung
the most common site.
• Treatment:
– Surgery (limb sparing) with
– Preoperative and postoperative Chemotherapy.
• Prognosis
– five-year survival 50-60%.
41. 41
• Exostosis ("osteochondroma”):
– Most common** benign bone tumor.
• Tumor: Mushroom shaped
– Composed of outgrowth of bone (exostoses)
capped by benign proliferating cartilage.
• Age: 10-30
• Location: Usually located in the metaphysis of
long bone.
• Can be: solitary or multiple
• If Multiple then k/a osteochondromatosis:
– Hereditary multiple exostoses
– Increased risk of transformation into
chondrosarcoma (if multiple).
43. 43
• Chondromas: benign tumor composed of hyaline
cartilage
• If located within shaft of bone then k/a
enchondroma.
– Site: small bones of hand and feet (proximal
phalanges).
– Can be
• Solitary
• Multiple (called enchondromatosis)
– Chondrosarcoma risk with multiple
tumors.
• Ollier’s disease : multiple enchondromas.
• Maffucci's syndrome : multiple enchondromas
plus hemangiomas of soft tissues.
48. 48
Chondrosarcoma
• A malignant tumor of chondroblasts.
• MC primary malignant cartilaginous tumors.
• Age: 40-60 years
• Location:
– Central skeleton: ribs, shoulder and
Pelvic bones and
– Upper end of femur and humerus
• Can arise
– de novo or
– secondary to osteochondromatosis or
enchondromatosis.
51. 51
• Gross:
– grayish blue, glistening and semi-
translucent.
• Micro:
– composed of atypical chondrocytes and
chondroblasts often with multiple nuclei in
a lacuna.
• Biologic behavior and Prognosis
– depends on the grade of tumor.
• Metastasis
– Hematogenously to lungs
54. 54
Ewing's Sarcoma
• An extremely malignant tumor composed of
small round blue cells.
– Arises within the marrow cavity.
• Histogenesis uncertain: Current evidence:
– Probably of neuroectodermal origin.
– Reasons:
• Specific translocation : t(11;22)
• Same translocation also present in similar
tumor of soft tissue known as PNET
(primitive neuro-ectodermal tumor).
55. 55
• Age:
– Most occur in teenagers 5-20 yrs
• Genetics:
– classic translocation t(11;22) which produces
the EWS-FLI1 fusion gene.
• Gross:
– Arises in medullary cavity in the diaphysis of
long bones.
– Most common sites are the femur, pelvis and
the tibia.
– Penetrates the cortex to produce :
• White tan mass with necrosis and
hemorrhage.
60. 60
• Microscopy:
– Tumor composed of
• Sheets of "small round blue cells"
with little cytoplasm.
• Cells are loaded with glycogen.
• Glycogen can be seen by PAS stain.
• Homer Wright rosettes (tumor cells
arranged in circle about a central
fibrillary space)
61. 61
• X ray:
– Concentric “onion skin” layering of new
periosteal bone.
• Clinical features:
– It presents “as an infection” with
• fever,
• Painful enlarging mass often tender
• Heat over the tumor.
– Therefore simulates osteomyelitis.
• Prognosis:
– Radiation + Chemotherapy+ surgery 75% 5-
year survival.
62. 62
• Differential diagnosis:
– Other small round blue cell tumors
• metastatic neuroblastoma
• metastatic malignant lymphoma
• acute lymphoblastic leukemia
• Rhabdomysarcoma
• IHC will help differentiate ES from these
small round blue cell tumors (SRBCT).
66. 66
Giant cell tumor ("osteoclastoma")
• A locally aggressive potentially malignant tumor
composed of :
– multinucleated giant cells (nonneoplastic)
admixed with mononuclear cells (neoplastic).
• More common in females than males.
• Seen in patients 20-40 years of age
• Arises in the epiphysis and extends into
metaphysis
• Favored locations:
– Classical : epiphysis of long bone.
– Sites most commonly affected:
• Lower end of femur> Upper end of
tibia >Lower end of radius.
73. 73
• Gross: Cut section of the tumor:
– Solid red brown mass with hemorrhage and
cystic degeneration
• Microscopy: Two components
• Osteoclast like giant cells:
– Large with 20-30 nuclei.
– Are Not neoplastic.
– Formed due to fusion of monocytes.
• Mononuclear stromal cells.
– Are the neoplastic cells and determine
the behavior.
• X-ray:A lytic expansile lesion in the epiphysis.
– May have a “soap bubble” appearance.
• Clinical behavior: Unpredictable
76. 76
Fibrous cortical defects and
Non-ossifying fibromas
• Essentially the same disease except for a
difference in size.
– Fibrous cortical defects : 1-4 cm
– Non-ossifying fibromas : 5-10 cm.
• Both are benign tumor like lesions
78. 78
Fibrous cortical defects and
Non-ossifying fibromas
• Clinical:
– Extremely common: (1/3rd of normal children)
– Asymptomatic / fracture
– Occur in the long leg bones of children
(cortical aspect of metaphysis).
– Femur>tibia>fibula
– Made of fibroblasts,and lipid-laden
macrophages
• X ray:
– irregular, sharply demarcated radiolucent
defect in the metaphyseal cortex.
• Treatment:
– often resolves spontaneously
79. 79
Fibrous dysplasia
• Benign non-neoplastic process of bones.
• Characterized by
1. replacement of marrow by fibrous tissue.
2. presence of poorly formed woven bone
arranged in Chinese letter pattern.
• Primarily targets ribs, femur, or cranial bones
of children and young adults.